Eelko Hak

14.0k total citations · 2 hit papers
315 papers, 9.8k citations indexed

About

Eelko Hak is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Health. According to data from OpenAlex, Eelko Hak has authored 315 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Epidemiology, 39 papers in Public Health, Environmental and Occupational Health and 37 papers in Health. Recurrent topics in Eelko Hak's work include Influenza Virus Research Studies (68 papers), Respiratory viral infections research (66 papers) and Pneumonia and Respiratory Infections (65 papers). Eelko Hak is often cited by papers focused on Influenza Virus Research Studies (68 papers), Respiratory viral infections research (66 papers) and Pneumonia and Respiratory Infections (65 papers). Eelko Hak collaborates with scholars based in Netherlands, Indonesia and Spain. Eelko Hak's co-authors include Elisabeth A. M. Sanders, Kristin L. Nichol, Andy I. M. Hoepelman, James D. Nordin, John P. Mullooly, Arno W. Hoes, K. J. Gorter, Guy E.H.M. Rutten, Maarten J. Postma and David Nelson and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Eelko Hak

302 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus

2005 743 citations Eelko Hak et al. profile →
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly

2007 497 citations Eelko Hak et al. profile →

Peers

Countries citing papers authored by Eelko Hak

Since Specialization

Citations

This map shows the geographic impact of Eelko Hak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eelko Hak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eelko Hak more than expected).

Fields of papers citing papers by Eelko Hak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eelko Hak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eelko Hak. The network helps show where Eelko Hak may publish in the future.

Co-authorship network of co-authors of Eelko Hak

This figure shows the co-authorship network connecting the top 25 collaborators of Eelko Hak. A scholar is included among the top collaborators of Eelko Hak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eelko Hak. Eelko Hak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dose, Kidney Function, and a Drug–Excipient Interaction Impair Mycophenolate Mofetil Prodrug Activation in Kidney Transplant Recipients 2025 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), (unknown), Daan Kremer, Tim J. Knobbe, Gérard Hopfgartner, Stephan J. L. Bakker, Eelko Hak, Frank Klont, (unknown)	0
2	Exploring the Reliability of Detecting Drug–Drug Interactions that Increase the Risk of Gestational Diabetes in Adverse Event Reporting Systems 2025 ·Drug Safety ·(unknown), Jim W. Barrett, (unknown), (unknown), G. Niklas Norén, Catharina C. M. Schuiling‐Veninga, Eelko Hak, Eugène van Puijenbroek	1
3	Switching pattern and dose adjustment of antidepressants before and during pregnancy 2023 ·Archives of Women s Mental Health ·(unknown), (unknown), Jens Bos, Eelko Hak, Eugène van Puijenbroek, Catharina C. M. Schuiling‐Veninga	1
4	The cost of implementing measles campaign in Nigeria: comparing the stand-alone and the integrated strategy 2023 ·Health Economics Review ·(unknown), Jurjen van der Schans, Samuel Bawa, Balcha Masresha, John Wagai, (unknown), Boubacar Dieng, (unknown), (unknown), (unknown), (unknown), Fiona Braka, André Bita, Eelko Hak	5
5	The Association between Deductibles and Cardiovascular Medication Adherence: A Retrospective Inception Cohort Study 2023 ·Drugs - Real World Outcomes ·(unknown), (unknown), Talitha Feenstra, Eelko Hak, Stijn de Vos	0
6	Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study 2023 ·Preventive Medicine Reports ·(unknown), Stijn de Vos, Jens Bos, Eelko Hak	2
7	Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus 2023 ·Pharmacoepidemiology and Drug Safety ·(unknown), Stijn de Vos, Sieta T. de Vries, Eelko Hak, Petra Denig	3
8	Assessing the Potential of Untargeted SWATH Mass Spectrometry-Based Metabolomics to Differentiate Closely Related Exposures in Observational Studies 2022 ·Metabolites ·Frank Klont, (unknown), Daan Kremer, Tim J. Knobbe, R. F. Bonner, Hans Blokzijl, Rinse K. Weersma, Stephan J. L. Bakker, (unknown), Eelko Hak, Daan J. Touw, Gérard Hopfgartner	4
9	Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative 2022 ·Utrecht University Repository (Utrecht University) ·(unknown), Johanna E. Emmens, (unknown), Stijn de Vos, Jens Bos, Bob Wilffert, Eelko Hak, Rudolf A. de Boer	14
10	Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study 2022 ·Cardiovascular Therapeutics ·(unknown), Stijn de Vos, Jens Bos, Eelko Hak	3
11	Metabolomics data complemented drug use information in epidemiological databases: pilot study of potential kidney donors 2021 ·Journal of Clinical Epidemiology ·Frank Klont, Daan Kremer, António W. Gomes‐Neto, Stefan P. Berger, Daan J. Touw, Eelko Hak, R. F. Bonner, Stephan J. L. Bakker, Gérard Hopfgartner	10
12	Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study 2020 ·Nutrients ·Isidor Minović, Lyanne M. Kieneker, Ron T. Gansevoort, Manfred Eggersdorfer, Daan J. Touw, (unknown), Margery A. Connelly, Rudolf A. de Boer, Eelko Hak, Jens Bos, Robin P. F. Dullaart, Ido P. Kema, Stephan J. L. Bakker	12
13	Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States 2019 ·PLoS ONE ·(unknown), Petra Denig, Jens Bos, Catharina C. M. Schuiling‐Veninga, Eelko Hak	51
14	A Retrospective Surveillance of the Antibiotics Prophylactic Use of Surgical Procedures in Private Hospitals in Indonesia 2018 ·Hospital Pharmacy ·(unknown), (unknown), Eelko Hak, (unknown), (unknown), Herman J. Woerdenbag, Christina Avanti	16
15	[Upward trend in the use of psychostimulants by adults]. 2017 ·PubMed ·Luke van der Koog, Jurjen van der Schans, (unknown), (unknown), (unknown), Eelko Hak, Catharina C. M. Schuiling‐Veninga	1
16	Poor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands: choice of antidepressant and dose 2016 ·European Child & Adolescent Psychiatry ·Ymkje Anna de Vries, Peter de Jonge, Luuk J. Kalverdijk, Jens Bos, Catharina C. M. Schuiling‐Veninga, Eelko Hak	9
17	Prenatal exposure to acid‐suppressive drugs and the risk of allergic diseases in the offspring: a cohort study 2013 ·Clinical & Experimental Allergy ·(unknown), Catharina C. M. Schuiling‐Veninga, H Bos, Tjalling W. de Vries, Susan S. Jick, Eelko Hak	28
18	Influenza vaccination of hospital healthcare staff from the perspective of the employer:a positive balance 2010 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Eelko Hak, (unknown), Jan Wilschut, Maarten J. Postma	3
19	Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination 2008 ·Vaccine ·(unknown), (unknown), Mark H. Rozenbaum, Paul B. van den Berg, Eelko Hak, Erik Buskens, Jan Wilschut, Aloys C.M. Kroes, Maarten J. Postma	8
20	Population-based prevention of influenza in Dutch general practice. 1997 ·PubMed ·Eelko Hak, Rosella Hermens, Gerrit A. van Essen, M. M. Kuyvenhoven, R A de Melker	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact